2025 Expert Speaker Faculty

Adrian Bot

Founding Chief Scientific Officer & Executive Vice President - Research & Development

Capstan Therapeutics

Artavazd Arumov

Principal

Qiming Venture Partners

Bin Wu

Founder & Chief Executive Officer

Cytodigm, Inc.

CΓ©cile Bauche

Founder & Chief Scientific Officer

Alaya.bio

Dana Foss

Chief Executive Officer & Co-Founder

Editpep

Daniel Getts

Chief Executive Officer

Myeloid Therapeutics

Delai Chen

Director - Nanoparticle Formulation

Beam Therapeutics Inc.

Dhaval Patel

Executive Vice President & Chief Scientific Officer

Sana Biotechnology

Eric Kmiec

Founder, Chief Executive & Scientific Officer

CorriXR Therapeutics

Gilmore O’Neill

President & Chief Executive Officer

Editas Medicine

Gregory Frost

Chairman & Chief Executive Officer

Exuma Biotechnology

Guobao Chen

Principal Scientist, Research

Abbvie

Laura Green

Director, Program Management

Umoja Biopharma

Maurits Geerlings

Co-Founder, President & CEO

NanoCell Therapeutics

Michael Klichinsky

Co-Founder & Chief Scientific Officer

Carisma Therapeutics

Robert Hofmeister

Chief Scientific Officer

Myeloid Therapeutics

Robert Peters

Chief Scientific Officer

Ensoma

Safi Shahda

Senior Director, Medical

Intellia Therapeutics

Tian Zhu

Chief Executive Officer & Co-Founder

GenEditBio

Xavier Duportet

Honorary President

Eligo Bioscience

Youngwook Won

Chief Executive Officer

Singular Immune

What Our Speaker Faculty Has To Say

β€˜I am thrilled to return to the 4th In Vivo Cell Engineering & Gene Summit, as last year's event provided invaluable insights into the latest advancements in in vivo cell and gene therapy and collaborative opportunities. I look forward to deepening my understanding of innovative techniques in gene editing and in vivo engineering this year.’

Bin Wu, Founder & Chief Executive Officer, Cytodigm

What Our Speaker Faculty Has To Say

β€˜As the field of cell & gene therapy rapidly evolves, this conference is an excellent venue to stay abreast of the latest developments’

Maurits Geerlings, Co-Founder, President, Chief Executive Officer, NanoCell Therapeutics
2025 Agenda
Register
Become a Partner